Aberdeen Group
MURA

Aberdeen Group’s Mural Oncology MURA Stock Holding History

Aberdeen Group’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,342
Closed -$79.9K – 970
2025
Q2 		$79.9K Hold
32,342
– – ﹤0.01% 948
2025
Q1 		$40.8K Hold
32,342
– – ﹤0.01% 940
2024
Q4 		$104K Hold
32,342
– – ﹤0.01% 928
2024
Q3 		$101K Hold
32,342
– – ﹤0.01% 913
2024
Q2 		$102K Hold
32,342
– – ﹤0.01% 941
2024
Q1 		$158K Hold
32,342
– – ﹤0.01% 934
2023
Q4 		$191K Buy
+32,342
New +$130K ﹤0.01% 945

Other funds holding MURA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Aberdeen Group's MURA Position: Q3 2025 in Review

Aberdeen Group sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 32,342 shares — an estimated $79.9K sold.

Aberdeen Group first reported a position in MURA in Q4 2023 and held it in 7 quarters. The position peaked at $191K in Q4 2023. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

  • Aberdeen Group reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
  • Aberdeen Group sold 32,342 Mural Oncology shares in Q3 2025, an estimated $79.9K.
  • Aberdeen Group first reported a position in Mural Oncology in Q4 2023 and held it in 7 quarters.
  • Aberdeen Group's Mural Oncology position peaked at $191K in Q4 2023.
  • 61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Aberdeen Group's 13F filing for Q3 2025, filed 7 Nov 2025.